Tafasitamab-Based Combination Boosts PFS in Relapsed/Refractory Follicular Lymphoma

Published Date: 13 Dec 2024

Benefit seen in all prespecified subgroups, including high-risk patients

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Beyond What Is Visible in Myelofibrosis?

2.

Gene therapy for glioblastoma is effectively created by researchers.

3.

Except for Black Patients, the Rates of Gallbladder Cancer Are Stable or Declining.

4.

Survival rates for incurable larynx cancer investigated for first time

5.

Rural-urban disparities seen in cervical cancer


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot